GliSODin by ISOCELL

📍 Paris, France🗓 Founded 2001👥 6 employees💰 Last funded 2012
Wellness and Fitness Services🌐 glisodin.com
Website LinkedIn
GliSODin is a trademark of ISOCELL. ISOCELL is a French biotech company based in Paris and specialized for more than 20 years in the protection against oxidative stress and its effects on aging. A leader in the field of anti-aging clinical research on oral route, ISOCELL develops and manufactures high-quality, clinically proven food supplements based on natural ingredients. ISOCELL operates in more than 30 countries: Japan, Korea, China, Canada, the United States, Mexico, India … and maintains special partnerships to develop GliSODin® based on natural food supplements for dermatology, but also for cardiology and immune treatments. In 2019, at IMCAS, ISOCELL presented to the medical community its latest advances in the benefits of the oral route for skin health and beauty. These conferences allowed more than 500 international physicians to witness the efficacy of the oral route on the skin. This work enhances the credibility and efficacy of GliSODin® food supplements for skin health and beauty, and is part of clinically proven expertise.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
2001
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
France
1
Frequently asked questions
Who invested in GliSODin by ISOCELL?
GliSODin by ISOCELL has 1 investors on record on gritt.io.
When did GliSODin by ISOCELL last raise funding?
The most recent investment in GliSODin by ISOCELL recorded on gritt.io was in 2012.
When was GliSODin by ISOCELL founded?
GliSODin by ISOCELL was founded in 2001.
What industry is GliSODin by ISOCELL in?
GliSODin by ISOCELL operates in Wellness and Fitness Services. Find similar Wellness and Fitness Services investors on gritt.io.
Where is GliSODin by ISOCELL based?
GliSODin by ISOCELL is headquartered in Paris, France.